Interestingly, the metastatic cancer cells acquired additional mutations in Wnt pathway components (APC mutations or amplifications of LRP6 and WNT2B), underlining the importance of Wnt signaling for metastasis [166]. This evidence concerns the gene LRP6 and cancer.